KEGG DRUG

Search results

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY	指定難病告示番号
1	Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab	4件: Bortezomib, Cyclophosphamide, Daratumumab, Dexamethasone	5件: Cyclophosphamide , Dexamethasone , Bortezomib , Cyclophosphamide , Daratumumab 💬	3件: CD38, NR3C1, PSMB5 💬	16件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬	1件: 28 💬
2	Daratumumab	1件: Daratumumab	1件: Daratumumab 💬	1件: CD38 💬	7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬	5件: 13, 28, 48, 49, 63 💬
3	Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20)	3件: Daratumumab, Hyaluronidase, Hyaluronidase (human recombinant)	4件: Hyaluronidase , Hyaluronidase , Hyaluronidase , Daratumumab 💬	1件: CD38 💬	7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬	1件: 28 💬
4	Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20)	1件: Daratumumab	1件: Daratumumab 💬	1件: CD38 💬	7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬	1件: 28 💬
5	Daratumumab Injection	1件: Daratumumab	1件: Daratumumab 💬	1件: CD38 💬	7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬	3件: 28, 49, 63 💬